New class of potent antitumor acylhydrazone derivatives containing furan

Z Cui, Y Li, Y Ling, J Huang, J Cui, R Wang… - European journal of …, 2010 - Elsevier
Z Cui, Y Li, Y Ling, J Huang, J Cui, R Wang, X Yang
European journal of medicinal chemistry, 2010Elsevier
A pair of chemical isomeric structures of N-acylhydrazone compounds I and II were
designed and synthesized. The reaction was carried out with high diastereoselectivity to
obtain one configurational isomer in excellent yields. The exact configuration and
conformation of IIa and IIe were confirmed by the X-ray single crystal diffraction. The
antitumor bioassay revealed that some compounds exhibited excellent activity against the
selected cancer cell lines. In particular, IIf (IC50= 16.4 μM) was better than doxorubicin …
A pair of chemical isomeric structures of N-acylhydrazone compounds I and II were designed and synthesized. The reaction was carried out with high diastereoselectivity to obtain one configurational isomer in excellent yields. The exact configuration and conformation of IIa and IIe were confirmed by the X-ray single crystal diffraction. The antitumor bioassay revealed that some compounds exhibited excellent activity against the selected cancer cell lines. In particular, IIf (IC50=16.4μM) was better than doxorubicin (IC50=53.3μM) against human promyelocytic leukemic cells (HL-60). Their toxicities were predicted in silico. The results showed that compounds II were safe and eligible to be development candidates. IIf showed great promise as a novel lead compound for further anticancer discovery.
Elsevier
以上显示的是最相近的搜索结果。 查看全部搜索结果